Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.3200
-0.07-18.26%
At close: -
$0.2901
-0.03-9.34%
After Hours: Mar 28, 5:32 PM EDT
Comments
Loading...
Co-Diagnostics Analyst Ratings and Price Targets | NASDAQ:CODX | Benzinga
Co-Diagnostics Inc has a consensus price target of $3 based on the ratings of 2 analysts. The high is $5 issued by Sidoti & Co. on August 12, 2022. The low is $1 issued by HC Wainwright & Co. on March 28, 2025. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on March 28, 2025, November 11, 2024, and August 12, 2024, respectively. With an average price target of $1.33 between HC Wainwright & Co., there's an implied 359.61% upside for Co-Diagnostics Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Sidoti & Co.
1calculated from analyst ratings
Analyst Ratings for Co-Diagnostics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/28/2025 | Buy Now | 244.71% | HC Wainwright & Co. | Yi Chen60% | $1.5 → $1 | Maintains | Neutral | Get Alert |
| 11/11/2024 | Buy Now | 417.06% | HC Wainwright & Co. | Yi Chen60% | $1.5 → $1.5 | Reiterates | Neutral → Neutral | Get Alert |
| 08/12/2024 | Buy Now | 417.06% | HC Wainwright & Co. | Yi Chen60% | $2 → $1.5 | Maintains | Neutral | Get Alert |
| 06/17/2024 | Buy Now | 589.42% | HC Wainwright & Co. | Yi Chen60% | $2 → $2 | Reiterates | Neutral → Neutral | Get Alert |
| 05/13/2024 | Buy Now | 589.42% | HC Wainwright & Co. | Yi Chen60% | $2.5 → $2 | Maintains | Neutral | Get Alert |
| 03/15/2024 | Buy Now | 761.77% | HC Wainwright & Co. | Yi Chen60% | $3 → $2.5 | Maintains | Neutral | Get Alert |
| 12/29/2023 | Buy Now | 934.13% | HC Wainwright & Co. | Yi Chen60% | $3 → $3 | Reiterates | Neutral → Neutral | Get Alert |
| 11/13/2023 | Buy Now | 934.13% | HC Wainwright & Co. | Yi Chen60% | $2 → $3 | Maintains | Neutral | Get Alert |
| 08/14/2023 | Buy Now | 589.42% | HC Wainwright & Co. | Yi Chen60% | $3 → $2 | Maintains | Neutral | Get Alert |
| 05/15/2023 | Buy Now | 934.13% | HC Wainwright & Co. | Yi Chen60% | → $3 | Reiterates | Neutral → Neutral | Get Alert |
| 03/20/2023 | Buy Now | 934.13% | HC Wainwright & Co. | Yi Chen60% | $6 → $3 | Downgrade | Buy → Neutral | Get Alert |
| 02/23/2023 | Buy Now | 1968.25% | HC Wainwright & Co. | Yi Chen60% | → $6 | Reiterates | → Buy | Get Alert |
| 11/14/2022 | Buy Now | 1968.25% | HC Wainwright & Co. | Yi Chen60% | $9 → $6 | Maintains | Buy | Get Alert |
| 08/15/2022 | Buy Now | 3002.38% | HC Wainwright & Co. | Yi Chen60% | $12 → $9 | Maintains | Buy | Get Alert |
| 08/12/2022 | Buy Now | 1623.54% | Sidoti & Co. | James Sidoti65% | → $5 | Downgrade | Buy → Neutral | Get Alert |
| 05/16/2022 | Buy Now | 4036.5% | HC Wainwright & Co. | Yi Chen60% | $15 → $12 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Co-Diagnostics (CODX) stock?
The latest price target for Co-Diagnostics (NASDAQ:CODX) was reported by HC Wainwright & Co. on March 28, 2025. The analyst firm set a price target for $1.00 expecting CODX to rise to within 12 months (a possible 244.71% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Co-Diagnostics (CODX)?
The latest analyst rating for Co-Diagnostics (NASDAQ:CODX) was provided by HC Wainwright & Co., and Co-Diagnostics maintained their neutral rating.
When was the last upgrade for Co-Diagnostics (CODX)?
There is no last upgrade for Co-Diagnostics
When was the last downgrade for Co-Diagnostics (CODX)?
The last downgrade for Co-Diagnostics Inc happened on March 20, 2023 when HC Wainwright & Co. changed their price target from $6 to $3 for Co-Diagnostics Inc.
When is the next analyst rating going to be posted or updated for Co-Diagnostics (CODX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Co-Diagnostics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Co-Diagnostics was filed on March 28, 2025 so you should expect the next rating to be made available sometime around March 28, 2026.
Is the Analyst Rating Co-Diagnostics (CODX) correct?
While ratings are subjective and will change, the latest Co-Diagnostics (CODX) rating was a maintained with a price target of $1.50 to $1.00. The current price Co-Diagnostics (CODX) is trading at is $0.29, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.